NASDAQ · Analyst Forecast

Ascendis Pharma A/S (ASND) Stock Forecast & Price Target

$272.12 NASDAQ: ASND Market Cap $17.85B

Price as of Nov 16, 2026 (intraday, delayed) · Analyst estimates retrieved Nov 13, 2026 · Source: Financial Modeling Prep (analyst estimates) (methodology)

Revenue and earnings estimates published by analysts covering Ascendis Pharma A/S (ASND), and the range of their price targets. Everything on this page is a forecast made by other people — DeltaScreener does not produce estimates or targets of its own.

For Ascendis Pharma A/S, analysts forecast revenue rising from EUR 708.27M in 2025 to EUR 3.39B in 2030; the average estimate for 2030 earnings per share is EUR 20.51; with published estimates ranging from EUR 18.99 to EUR 23.32; 15 analysts contribute to these figures. These are forecasts published by analysts, not results.

Analyst price targets

MeasureValue
Current priceWhat the share trades at now.$272.12
Consensus targetThe average of the price targets analysts have published.$306.33
Median targetThe middle target, less affected by a single outlier.$315.50
Highest targetThe most optimistic published target.$344.00
Lowest targetThe most pessimistic published target.$268.00
Difference from priceHow far the consensus target sits from today’s price.+12.6%

A price target is one analyst's forecast of where a share might trade, usually over twelve months. Targets are frequently revised, they disagree with each other, and they are not a measure of what a company is worth.

Revenue forecast (EUR)

The spread between low and high is how far analysts disagree, which is usually a better guide than the average alone.

YearLowAverageHighAnalysts
2025EUR 703.05MEUR 708.27MEUR 719.69M12
2026EUR 1.29BEUR 1.34BEUR 1.44B15
2027EUR 1.89BEUR 1.97BEUR 2.08B15
2028EUR 2.21BEUR 2.49BEUR 2.75B15
2029EUR 2.80BEUR 2.97BEUR 3.29B10
2030EUR 3.19BEUR 3.39BEUR 3.75B11

Earnings per share forecast (EUR)

YearLowAverageHighAnalysts
2025−EUR 4.03−EUR 3.35−EUR 1.7812
2026EUR 10.93EUR 14.35EUR 16.4515
2027EUR 4.83EUR 9.00EUR 11.6215
2028EUR 7.25EUR 13.90EUR 19.8515
2029EUR 15.88EUR 17.15EUR 19.5010
2030EUR 18.99EUR 20.51EUR 23.3211

Ascendis Pharma A/S (ASND) forecast — frequently asked questions

What is the analyst price target for Ascendis Pharma A/S?

Analysts covering Ascendis Pharma A/S (ASND) have a consensus price target of $306.33, 12.6% above the current price of $272.12. Published targets range from $268.00 to $344.00. A price target is a forecast, not a measure of value, and targets are revised often.

What are analysts forecasting for Ascendis Pharma A/S's earnings?

The average analyst estimate for Ascendis Pharma A/S (ASND) earnings per share in 2030 is 20.51, with individual estimates between 18.99 and 23.32.

How much revenue is Ascendis Pharma A/S expected to make?

Analysts forecast Ascendis Pharma A/S (ASND) revenue of EUR 3.39B in 2030, based on 11 published estimates.

How many analysts cover ASND?

15 analysts contribute estimates for Ascendis Pharma A/S (ASND). Thin coverage makes an average less reliable.

Analyst forecasts for other Biotechnology stocks

VRTX forecastREGN forecastMRNA forecastRVMD forecastROIV forecastINSM forecastUTHR forecastINCY forecastALNY forecastEXEL forecastAll Biotechnology stocks

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksNasdaq High ROE StocksAll stock screens

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.